KB Financial Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$75K Buy
1,422
+290
+26% +$15.2K 0.02% 221
2023
Q2
$61K Buy
1,132
+1,087
+2,416% +$56.8K 0.02% 242
2023
Q1
$2K Hold
45
﹤0.01% 494
2022
Q4
$2K Hold
45
﹤0.01% 495
2022
Q3
$2K Hold
45
﹤0.01% 491
2022
Q2
$2K Sell
45
-9,512
-100% -$387K ﹤0.01% 492
2022
Q1
$423K Buy
9,557
+1,150
+14% +$49.8K 0.12% 101
2021
Q4
$357K Buy
+8,407
New +$353K 0.1% 116
2021
Q3
Sell
-45
Closed -$2K 221
2021
Q2
$2K Sell
45
-1,193
-96% -$50.2K ﹤0.01% 547
2021
Q1
$48K Buy
+1,238
New +$46.9K 0.02% 265

Other funds holding BSX

KB Financial Partners's BSX Position: Q3 2023 in Review

KB Financial Partners increased its Boston Scientific (BSX) stake by 26% in Q3 2023, buying an estimated $15.2K and bringing the position to 1,422 shares worth $75K. The position accounts for 0.02% of the portfolio, ranked #221.

KB Financial Partners first reported a position in BSX in Q1 2021 and has held it in 10 quarters since. The position peaked at $423K in Q1 2022. 1,056 funds tracked by Wall St. Rank hold BSX as of Q3 2023.

  • KB Financial Partners held 1,422 shares of Boston Scientific worth $75K as of Q3 2023.
  • KB Financial Partners bought 290 Boston Scientific shares in Q3 2023, an estimated $15.2K.
  • Boston Scientific made up 0.02% of KB Financial Partners's portfolio in Q3 2023, its #221 holding.
  • KB Financial Partners first reported a position in Boston Scientific in Q1 2021 and has held it in 10 quarters since.
  • KB Financial Partners's Boston Scientific position peaked at $423K in Q1 2022.
  • 1,056 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.